0001157523-12-001476.txt : 20120321 0001157523-12-001476.hdr.sgml : 20120321 20120321114148 ACCESSION NUMBER: 0001157523-12-001476 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20120320 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20120321 DATE AS OF CHANGE: 20120321 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DEX ONE Corp CENTRAL INDEX KEY: 0000030419 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-ADVERTISING [7310] IRS NUMBER: 132740040 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-07155 FILM NUMBER: 12705176 BUSINESS ADDRESS: STREET 1: 1001 WINSTEAD DRIVE CITY: CARY STATE: NC ZIP: 27513 BUSINESS PHONE: 9198046000 MAIL ADDRESS: STREET 1: 1001 WINSTEAD DRIVE CITY: CARY STATE: NC ZIP: 27513 FORMER COMPANY: FORMER CONFORMED NAME: R H DONNELLEY CORP DATE OF NAME CHANGE: 19980716 FORMER COMPANY: FORMER CONFORMED NAME: DUN & BRADSTREET CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: DUN & BRADSTREET COMPANIES INC DATE OF NAME CHANGE: 19790429 8-K 1 a50212061.htm DEX ONE CORPORATION 8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

______________

FORM 8-K

CURRENT REPORT
______________

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  March 20, 2012

______________

DEX ONE CORPORATION
 (Exact name of registrant as specified in its charter)
______________

Delaware 1-07155 13-2740040

(State or other jurisdiction
of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

 

1001 Winstead Drive,

Cary, NC

(Address of principal executive offices)

Registrant’s telephone number,

including area code:
(919) 297-1600

27513

(Zip Code)

 
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Item 8.01

Other Events.

On March 20, 2012, Dex One Corporation issued a press release announcing its commencement of a cash tender offer to purchase up to the maximum aggregate principal amount of its outstanding 12% / 14% Senior Subordinated Notes due 2017 that it can purchase for $26 million.  A copy of the press release announcing the cash tender offer is attached hereto as Exhibit 99.1 and incorporated by reference herein.

Item 9.01

Financial Statements and Exhibits.

  (d) Exhibits.
 
 
The following exhibit is filed with this report:
 

Exhibit No.

Exhibit Description

 
99.1 Press Release of Dex One Corporation issued March 20, 2012.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

DEX ONE CORPORATION

 
/s/ Mark W. Hianik
Mark W. Hianik

Senior Vice President, General Counsel

   & Chief Administrative Officer

 
 

 

Date: March 21, 2012


EXHIBIT INDEX

Exhibit No.

Exhibit Description

 
99.1

Press Release of Dex One Corporation issued March 20, 2012.

EX-99.1 2 a50212061-ex991.htm EXHIBIT 99.1

Exhibit 99.1

Dex One Corporation Announces Cash Tender Offer for a Portion of Its Outstanding 12% / 14% Senior Subordinated Notes Due 2017

CARY, N.C.--(BUSINESS WIRE)--March 20, 2012--Dex One Corporation (NYSE:DEXO) today announced the commencement of a cash tender offer to purchase the maximum aggregate principal amount of its outstanding 12% / 14% Senior Subordinated Notes due 2017 (the “Notes”) that it can purchase for $26.0 million, excluding cash in lieu of accrued interest on the Notes accepted for purchase calculated from March 31, 2012 through but not including the payment date at a rate of 12% per annum.

The tender offer is being made pursuant to an Offer to Purchase and a related Letter of Transmittal, each dated as of March 20, 2012. The tender offer will expire at 9:00 a.m., New York City time, on April 19, 2012 (as such time and date may be extended or earlier terminated, the “Expiration Date”). Notes validly tendered may be validly withdrawn at or prior to 9:00 a.m., New York City time, on April 19, 2012 (as such time and date may be extended).

As of March 20, 2012, the outstanding aggregate principal amount of the Notes is $300.0 million. On April 2, 2012, the next interest payment date for the Notes (the “Interest Payment Date”), the outstanding aggregate principal amount of the Notes is expected to increase to $310.5 million as a result of Dex One electing its option to pay 50% of the interest payment due on the Interest Payment Date in the form of additional Notes, in accordance with the terms of the related indenture.

The “total consideration” for Notes validly tendered and not validly withdrawn on or prior to the Expiration Date and accepted by Dex One for purchase will be calculated per $1,000 principal amount of Notes validly tendered, and not validly withdrawn, on or prior to the Expiration Date and accepted for purchase by Dex One pursuant to a modified “Dutch Auction,” as described in the Offer to Purchase. The purchase price range for Notes accepted for purchase, as described in the Offer to Purchase, will be $270 to $300 per $1,000 principal amount of such Notes plus an amount in cash in lieu of the accrued and unpaid interest on such Notes, calculated at a rate of 12% per annum (the applicable rate for interest payments on the Notes made solely in cash) on the aggregate principal amount of such Notes from March 31, 2012 to, but not including, the payment date. Dex One expects the payment date to be not later than the third New York Stock Exchange trading day following the Expiration Date.


This press release does not constitute a notice of redemption under the optional redemption provisions of the indenture governing the Notes, nor does it constitute an offer to sell, or a solicitation of an offer to buy, any security, nor does it constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale is unlawful.

The tender offer is contingent upon the satisfaction of certain conditions, as described in the Offer to Purchase. Full details of the terms and conditions of the tender offer are included in the Offer to Purchase.

Requests for documents relating to the tender offer (including the Offer to Purchase and the Letter of Transmittal) may be directed to D.F. King & Co., Inc., the Information Agent and the Tender Agent, at (800) 549-6650 (Toll-Free) or (212) 269-5550. Houlihan Lokey will act as Dealer Manager for the tender offer. Questions regarding the tender offer may be directed to the Liability Management Group of Houlihan Lokey at (212) 497-7864.

About Dex One Corporation

Dex One Corporation (NYSE: DEXO) is a leading marketing solutions provider helping local businesses and their customers connect wherever and whenever they choose to search.

Building on its heritage of delivering print-based solutions, the company provides integrated products and services to help its clients establish their digital presence and generate leads. Dex One’s locally based marketing experts offer a broad network of local marketing solutions including online, mobile and print search solutions, such as DexKnows.com. For more information, visit www.DexOne.com.

Certain statements contained in this press release regarding the tender offer, including whether or when the tender offer will be consummated and the purchase price for the Notes and any other statements not constituting historical fact are “forward-looking statements.” All forward-looking statements reflect only Dex One’s current beliefs and assumptions with respect to future business plans, prospects, decisions and results, and are based on information currently available to Dex One. Accordingly, the statements are subject to significant risks, uncertainties and contingencies, which could cause Dex One’s actual operating results, performance or business plans or prospects to differ materially from those expressed in, or implied by, these statements.

CONTACT:
Dex One Corporation
Media Contact:
Chris Hardman, 303-784-1351
chris.hardman@dexone.com
or
Investor Contact:
Jamie Andelman, 800-497-6329
invest@dexone.com